An exploratory study to investigate the impact on the viral reservoir of adding a broadly neutralizing antibody with or without an attachment inhibitor to an integrase inhibitor-based antiretroviral therapy regimen in adults living with HIV (ENTRANCE)
221794
Phase 1 other active
Quick answer
An exploratory study to investigate the impact on the viral reservoir of adding a broadly neutralizing antibody with or without an attachment inhibitor to an integrase inhibitor-based antiretroviral therapy regimen in adults living with HIV (ENTRANCE) for HIV Infections is a Phase 1 program (other) at ViiV Healthcare BV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ViiV Healthcare BV
- Indication
- HIV Infections
- Phase
- Phase 1
- Modality
- other
- Status
- active